Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS-Reference-Cited by-同舟云学术

Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS

Published:2016-05-18 Issue:24 Volume:7 Page:37000-37012
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

He Feng¹,Wei Lili²,Luo Wenqi²,Liao Zhipeng¹,Li Bo¹,Zhou Xiaoying¹,Xiao Xue¹,You Jingping¹,Chen Yufeng¹,Zheng Shixing¹,Li Ping²,Murata Mariko³,Huang Guangwu¹,Zhang Zhe¹

Affiliation:

1. Department of Otolaryngology-Head and Neck Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China

2. Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, China

3. Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Mie, Japan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and characterization of multidomain monothiol glutaredoxin 3 from diploblastic Hydra;Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology;2024-08

2. Glutathione-Dependent Pathways in Cancer Cells;International Journal of Molecular Sciences;2024-08-01

3. Glutaredoxin 3 (GLRX3) confers a fusion oncogene-dependent vulnerability to Ewing sarcoma;2024-04-26

4. Mechanistic insights into the antitumoral potential and in vivo antiproliferative efficacy of a silver-based core@shell nanosystem;International Journal of Pharmaceutics;2024-04

5. Effects of Antioxidant Gene Overexpression on Stress Resistance and Malignization In Vitro and In Vivo: A Review;Antioxidants;2022-11-23